Table 2.
Morphometry: Progression pattern
| Morphometric parameter | Benign (n=25) | ADH (n=4) | DCIS (n=3) | Invasive carcinoma (n=50) |
|---|---|---|---|---|
| Nuclear area | 28.14 ± 7.91 | 30.45 ± 7.04 | 85.63 ± 5.10 | 94.71 ± 19.94 |
| Perimeter | 19.63 ± 2.48 | 20.62 ± 2.15 | 32.37 ± 2.15 | 36.42 ± 4.95 |
| Shape | 1.09 ± 0.04 | 1.04 ± 0.002 | 1.04 ± 0.006 | 1.09 ± 0.04 |
| Long axis | 6.83 ± 0.91 | 7.14 ± 0.53 | 12.02 ± 0.59 | 13.61 ± 1.55 |
| Short axis | 4.88 ± 0.85 | 5.38 ± 0.75 | 8.63 ± 0.54 | 9.28 ± 1.27 |
| Intensity | 116.32 ± 11.18 | 101.22 ± 0.81 | 92.64 ± 6.21 | 119.23 ± 19.03 |
| Long run emphasis | 1.34 ± 0.19 | 1.12 ± 0.01 | 1.17 ± 0.05 | 1.2 ± 0.08 |
| Total run length | 1116.09 ± 454.83 | 1524.38 ± 447.42 | 4043.24 ± 209.25 | 4175.95 ± 1141.87 |
| T1 homogeneity | 0.0066 ± 0.0003 | 0.0067 ± 0.0004 | 0.006 ± 0.0006 | 0.0073 ± 0.0013 |
ADH, atypical ductal hyperplasia; DCIS, ductal carcinoma in situ